You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 6, 2026

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
Published on: October 20, 2023
Benjamin A Kelvington1,2,3, Jaekyoon Kim1,2, Regan Fair1,2,4
1Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa.
Elevated complement component 3 (C3) in the brain is linked to neurodevelopmental disorders (NDDs). Inhibiting the C3a receptor reduced hyperactivity in mouse models, suggesting complement system modulation for NDD treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: